Pancreatic Ductal Adenocarcinoma: A Strong Imbalance of Good and Bad Immunological Cops in the Tumor Microenvironment

Pancreatic ductal adenocarcinoma (PDAC) is one of the most aggressive and lethal cancers with very few available treatments. For many decades, gemcitabine was the only treatment for patients with PDAC. A recent attempt to improve patient survival by combining this chemotherapy with FOLFIRINOX and na...

全面介紹

書目詳細資料

發表在:	Frontiers in Immunology
Main Authors:	Etienne D. Foucher, Clément Ghigo, Salem Chouaib, Jérôme Galon, Juan Iovanna, Daniel Olive
格式:	Article
語言:	英语
出版:	Frontiers Media S.A. 2018-05-01
主題:	pancreatic ductal adenocarcinoma immune infiltrate tumor microenvironment immunosuppression hypoxia immune checkpoint
在線閱讀:	http://journal.frontiersin.org/article/10.3389/fimmu.2018.01044/full